| |
| |
|
| Insider
Information: |
Sinha Vikas |
| Relationship: |
|
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,308,459 |
|
|
Indirect Shares
|
16,674,766 |
|
|
| Direct
Value |
$33,419,819 |
|
|
|
Indirect Value
|
$12,547,761 |
|
|
| Total
Shares |
17,983,225 |
|
|
| Total
Value |
$45,967,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
23
|
|
Stock
price went up :
|
0
|
8
|
| Stock
price went down : |
0
|
15
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -725.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
EVP & CFO |
2016-08-08 |
178,463 |
2005-09-21 |
0 |
Premium* |
|
|
Allovir Inc |
ALVR |
|
2024-05-17 |
1,129,996 |
2024-05-17 |
16,674,766 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALVR |
Allovir Inc |
See Remarks |
• • • |
2024-02-05 |
4 |
S |
$0.67 |
$12,282 |
D/D |
(18,331) |
1,145,252 |
0 |
% |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-10-31 |
4 |
OE |
$17.65 |
$346,186 |
D/D |
19,307 |
182,077 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-10-31 |
4 |
AS |
$195.18 |
$3,768,340 |
D/D |
(19,307) |
162,770 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• – – |
2005-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-03-25 |
4 |
AS |
$55.00 |
$1,100,000 |
D/D |
(20,000) |
54,307 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-03-25 |
4 |
OE |
$13.79 |
$275,800 |
D/D |
20,000 |
74,307 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-09-28 |
4 |
OE |
$13.79 |
$275,800 |
D/D |
20,000 |
85,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-09-28 |
4 |
AS |
$65.01 |
$1,300,200 |
D/D |
(20,000) |
65,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-11-03 |
4 |
AS |
$70.00 |
$1,400,000 |
D/D |
(20,000) |
69,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-11-19 |
4 |
AS |
$75.00 |
$1,500,000 |
D/D |
(20,000) |
73,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-11-19 |
4 |
OE |
$13.79 |
$275,800 |
D/D |
20,000 |
93,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-02-14 |
4 |
S |
$90.00 |
$1,800,000 |
D/D |
(20,000) |
86,480 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2012-01-09 |
4 |
AS |
$75.55 |
$1,511,000 |
D/D |
(20,000) |
357,767 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2012-03-20 |
4 |
OE |
$10.29 |
$226,339 |
D/D |
21,996 |
385,384 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2012-03-20 |
4 |
AS |
$89.93 |
$1,978,100 |
D/D |
(21,996) |
363,388 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-11-03 |
4 |
OE |
$13.79 |
$341,200 |
D/D |
24,000 |
73,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-12-02 |
4 |
OE |
$17.98 |
$449,500 |
D/D |
25,000 |
187,770 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-12-02 |
4 |
AS |
$200.16 |
$5,004,000 |
D/D |
(25,000) |
162,770 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-02-14 |
4 |
OE |
$13.79 |
$378,741 |
D/D |
25,002 |
106,480 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-07-25 |
4 |
AS |
$58.27 |
$1,484,514 |
D/D |
(25,434) |
352,974 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-07-25 |
4 |
OE |
$5.18 |
$141,095 |
D/D |
25,434 |
378,408 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2012-01-09 |
4 |
OE |
$5.18 |
$203,570 |
D/D |
25,664 |
377,767 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-07-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
25,974 |
134,321 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • – |
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
29,400 |
939,656 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-02-22 |
4 |
AS |
$50.01 |
$1,500,300 |
D/D |
(30,000) |
54,307 |
0 |
- |
|
145 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
